Live Breaking News & Updates on Woosub Shin

Stay updated with breaking news from Woosub shin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GC Pharma Lights Up to Celebrate World Hemophilia Day

GC Pharma Lights Up to Celebrate World Hemophilia Day
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

South Korea , South Korean , Hyungoo Kang , Frank Schnabel , Yelin Jun , Woosub Shin , Hansaem Kim , World Federation Of Hemophilia , Green Cross Corporation , World Hemophilia , World Federation , World Hemophilia Day , Cross Corporation , தெற்கு கொரியா , தெற்கு கொரியன் , வெளிப்படையான ஶ்ந்யாபெல் , உலகம் கூட்டமைப்பு ஆஃப் ஹீமோபிலியா , பச்சை குறுக்கு நிறுவனம் , உலகம் ஹீமோபிலியா , உலகம் கூட்டமைப்பு , உலகம் ஹீமோபிலியா நாள் , குறுக்கு நிறுவனம் ,

GC Pharma Submits Biologics License Application to US FDA for Immune Globulin 'GC5107'

Press release content from Business Wire. The AP news staff was not involved in its creation.
GC Pharma Submits Biologics License Application to US FDA for Immune Globulin ‘GC5107’
February 26, 2021 GMT
YONGIN, South Korea (BUSINESS WIRE) Feb 25, 2021
GC Pharma (006280.KS) today announced that it had submitted its Biologics License Application (BLA) for ‘GC5107’ (Immune Globulin Intravenous (Human),10% Liquid) to the United States Food and Drug Administration (FDA).
GC Pharma demonstrated positive results in a Phase III study in North America, meeting its primary efficacy endpoint of acute serious bacterial infections (SBI). In the trials included in the submission, with PI (Primary Humoral Immunodeficiency) patients, all primary efficacy and safety endpoints corresponding to FDA guidelines were satisfied. ....

United States , South Korea , Hyungoo Kang , Yelin Jun , Woosub Shin , Hansaem Kim , Eun Chul Huh , Drug Administration , Green Cross Corporation , Biologics License Application , Immune Globulin Intravenous , United States Food , North America , Primary Humoral Immunodeficiency , Cross Corporation , Business Wire , Pharmaceutical Manufacturing , Health Care Industry , Medical Biotechnology Industry , East Asia , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , ஏன் சுல் ஹூ , பச்சை குறுக்கு நிறுவனம் , உயிரியல் உரிமம் விண்ணப்பம் , ஒன்றுபட்டது மாநிலங்களில் உணவு ,

GC Pharma Reports Full Year 2020 Results

Press release content from Business Wire. The AP news staff was not involved in its creation.
GC Pharma Reports Full Year 2020 Results
February 9, 2021 GMT
YONGIN, South Korea (BUSINESS WIRE) Feb 9, 2021
GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited financial results for the year ended 31 December 2019.
Key Figures (1)
-
(1) Results from continuing operations (Green Cross MS’ blood bag business has been classified as discontinued operations)
(2) Results and percentages compare full financial year 2019
Financial Highlights
Delivered total revenue growth of 10.8% to KRW 1,504.1 billion (2019: 1,357.1 billion), and operation profit increased 20.6% to KRW 50.2 billion (2019: 41.7 billion) in the full year of 2020 ....

United States , South Korea , South Korean , Hyungoo Kang , Woosub Shin , Cross Labcell , Green Cross Corporation , Green Cross , Genef China , Cross Corporation , Business Wire , Corporate News , Pharmaceutical Manufacturing , Health Care Industry , East Asia , Earnings Reports , Medical Biotechnology Industry , Financial Performance , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , தெற்கு கொரியன் , பச்சை குறுக்கு நிறுவனம் , பச்சை குறுக்கு , குறுக்கு நிறுவனம் , வணிக கம்பி , பெருநிறுவன செய்தி ,